Home/Filings/4/0000905148-24-001016
4//SEC Filing

Rojkjaer Lisa 4

Accession 0000905148-24-001016

CIK 0001034842other

Filed

Mar 28, 8:00 PM ET

Accepted

Mar 29, 4:09 PM ET

Size

5.3 KB

Accession

0000905148-24-001016

Insider Transaction Report

Form 4
Period: 2024-03-27
Rojkjaer Lisa
EVP, Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2024-03-27+187,500187,500 total
    Exercise: $1.49Exp: 2034-03-27Common Stock (187,500 underlying)
Footnotes (1)
  • [F1]One-fourth (1/4th) of the shares subject to this option vest on March 11, 2025, and 1/48th of the shares subject to this option vest in substantially equal monthly installments over the thirty-six (36) months thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date.

Documents

1 file

Issuer

RIGEL PHARMACEUTICALS INC

CIK 0001034842

Entity typeother

Related Parties

1
  • filerCIK 0001846460

Filing Metadata

Form type
4
Filed
Mar 28, 8:00 PM ET
Accepted
Mar 29, 4:09 PM ET
Size
5.3 KB